These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23398967)

  • 1. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
    Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
    Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.
    Renson P; Le Dimna M; Gabriel C; Levai R; Blome S; Kulcsar G; Koenen F; Le Potier MF
    Res Vet Sci; 2014 Apr; 96(2):389-95. PubMed ID: 24530018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
    Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
    Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
    Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
    Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
    Koenig P; Lange E; Reimann I; Beer M
    Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.
    Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S
    Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.
    Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL
    Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
    Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
    Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
    Aebischer A; Müller M; Hofmann MA
    Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
    von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
    Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.
    Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M
    Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.
    Pannhorst K; Fröhlich A; Staubach C; Meyer D; Blome S; Becher P
    J Vet Diagn Invest; 2015 Jul; 27(4):449-60. PubMed ID: 26179095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
    Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S
    Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
    Reimann I; Depner K; Trapp S; Beer M
    Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
    Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
    Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The double-antigen ELISA concept for early detection of E
    Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A
    Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.
    Blome S; Aebischer A; Lange E; Hofmann M; Leifer I; Loeffen W; Koenen F; Beer M
    Vet Microbiol; 2012 Jul; 158(1-2):42-59. PubMed ID: 22397931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn
    Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S
    Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ
    J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.
    Feliziani F; Blome S; Petrini S; Giammarioli M; Iscaro C; Severi G; Convito L; Pietschmann J; Beer M; De Mia GM
    Vaccine; 2014 Apr; 32(18):2050-5. PubMed ID: 24565752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.